Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023

BUY
$36.12 - $41.79 $253,381 - $293,156
7,015 New
7,015 $257,000
Q4 2022

Feb 02, 2023

BUY
$41.75 - $54.5 $277,762 - $362,588
6,653 New
6,653 $341,000
Q2 2022

Jul 27, 2022

SELL
$46.53 - $55.17 $405,974 - $481,358
-8,725 Closed
0 $0
Q1 2022

May 03, 2022

SELL
$45.75 - $56.69 $17,385 - $21,542
-380 Reduced 4.17%
8,725 $452,000
Q4 2021

Feb 09, 2022

SELL
$41.32 - $61.25 $4,297 - $6,370
-104 Reduced 1.13%
9,105 $538,000
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $14,483 - $18,604
-369 Reduced 3.85%
9,209 $396,000
Q2 2021

Aug 05, 2021

BUY
$35.91 - $40.68 $610 - $691
17 Added 0.18%
9,578 $375,000
Q1 2021

May 07, 2021

BUY
$33.49 - $37.77 $320,197 - $361,118
9,561 New
9,561 $346,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Appleton Group, LLC Portfolio

Follow Appleton Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Appleton Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Appleton Group, LLC with notifications on news.